We develop clinically driven, first-in-class, tissue-specific therapeutics from human diseased tissue to treat specific fibrotic disease populations.
Company Details
- Employees
- 11
- Founded
- 2017
- Address
- 661 University Ave, Suite 1300,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- fibrocortherapeutics.net
- Keywords
- Fibrotic Disease.
- HQ
- Toronto, M5G 0B7
Fibrocor Therapeutics Questions
Fibrocor Therapeutics's website is fibrocortherapeutics.net
Fibrocor Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/fibrocor-therapeutics
Fibrocor Therapeutics has
11 employees.
View email and phone details for 11
employees at Fibrocor Therapeutics.
Fibrocor Therapeutics's industry is
Biotechnology Research
Fibrocor Therapeutics's top competitors are
Virica Biotech,
Ability Biotherapeutics,
Seragene Therapeutics,
Biotecanada,
Ripple Therapeutics,
Qurcan Therapeutics Inc.,
Reverb Therapeutics,
Edesa Biotech, Inc.,
Noa Therapeutics,
Amacathera.
Fibrocor Therapeutics's categories are Biotechnology Research
Fibrocor Therapeutics's founding year is 2017
